These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17380276)

  • 41. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biliary innate immunity in the pathogenesis of biliary diseases.
    Harada K; Nakanuma Y
    Inflamm Allergy Drug Targets; 2010 Jun; 9(2):83-90. PubMed ID: 20402650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary biliary cirrhosis: a multi-faced interactive disease involving genetics, environment and the immune response.
    Uibo R; Kisand K; Yang CY; Gershwin ME
    APMIS; 2012 Nov; 120(11):857-71. PubMed ID: 23009110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein Immunization.
    Ma WT; Liu QZ; Yang JB; Yang YQ; Zhao ZB; Ma HD; Gershwin ME; Lian ZX
    Sci Rep; 2017 Nov; 7(1):15246. PubMed ID: 29127360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pathogenesis of biliary tract injury in primary biliary cirrhosis].
    Ishibashi H; Shimoda S
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(6):455-62. PubMed ID: 23291480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis.
    Harada K; Shimoda S; Sato Y; Isse K; Ikeda H; Nakanuma Y
    Clin Exp Immunol; 2009 Aug; 157(2):261-70. PubMed ID: 19604266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis.
    Harada K; Sudo Y; Kono N; Ozaki S; Tsuneyama K; Gershwin ME; Nakanuma Y
    Hepatology; 1999 Jul; 30(1):36-45. PubMed ID: 10385636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New insights into autoimmune cholangitis through animal models.
    Trauner M; Fickert P; Baghdasaryan A; Claudel T; Halilbasic E; Moustafa T; Wagner M; Zollner G
    Dig Dis; 2010; 28(1):99-104. PubMed ID: 20460897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoimmunity and primary biliary cirrhosis.
    Mackay IR
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):519-33. PubMed ID: 10976012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.
    Huang W; Kachapati K; Adams D; Wu Y; Leung PS; Yang GX; Zhang W; Ansari AA; Flavell RA; Gershwin ME; Ridgway WM
    J Autoimmun; 2014 May; 50():123-34. PubMed ID: 24556277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunological abnormalities in patients with primary biliary cholangitis.
    Ma WT; Chen DK
    Clin Sci (Lond); 2019 Mar; 133(6):741-760. PubMed ID: 30890652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis.
    Shimoda S; Van de Water J; Ansari A; Nakamura M; Ishibashi H; Coppel RL; Lake J; Keeffe EB; Roche TE; Gershwin ME
    J Clin Invest; 1998 Nov; 102(10):1831-40. PubMed ID: 9819369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum reactivity against bacterial pyruvate dehydrogenase: increasing the specificity of anti-mitochondrial antibodies for the diagnosis of primary biliary cirrhosis.
    Miyakawa H; Tanaka A; Selmi C; Hosoya N; Mataki N; Kikuchi K; Kato T; Arai J; Goto T; Gershwin ME
    Clin Dev Immunol; 2006; 13(2-4):289-94. PubMed ID: 17162370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Addison's other disease: primary biliary cirrhosis as a model autoimmune disease.
    Jones DE
    Clin Med (Lond); 2003; 3(4):351-6. PubMed ID: 12938751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Primary biliary cirrhosis (PBC): concept, pathogenesis and classification].
    Aizawa Y; Toda G
    Nihon Rinsho; 1994 Jan; 52(1):240-56. PubMed ID: 8114300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex.
    Jones DE; Palmer JM; Burt AD; Walker C; Robe AJ; Kirby JA
    Hepatology; 2002 Sep; 36(3):679-86. PubMed ID: 12198661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary biliary cirrhosis: overlaps with other autoimmune disorders.
    Floreani A; Franceschet I; Cazzagon N
    Semin Liver Dis; 2014 Aug; 34(3):352-60. PubMed ID: 25057958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Depletion of CD8+ cells exacerbates organ-specific autoimmune diseases induced by CD4+ T cells in semiallogeneic hosts with MHC class II disparity.
    Saitoh T; Ikarashi Y; Ito S; Watanabe H; Fujiwara M; Asakura H
    J Immunol; 1990 Nov; 145(10):3268-75. PubMed ID: 2121823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis.
    Migliaccio C; Nishio A; Van de Water J; Ansari AA; Leung PS; Nakanuma Y; Coppel RL; Gershwin ME
    J Immunol; 1998 Nov; 161(10):5157-63. PubMed ID: 9820485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PDC-E3BP is not a dominant T-cell autoantigen in primary biliary cirrhosis.
    McHugh A; Robe AJ; Palmer JM; Jones DE
    Liver Int; 2006 May; 26(4):406-13. PubMed ID: 16629643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.